The Gut and Skin Microbiome in Vitiligo Disease Progression
1 other identifier
observational
100
1 country
1
Brief Summary
Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2018
CompletedFirst Posted
Study publicly available on registry
July 5, 2018
CompletedStudy Start
First participant enrolled
May 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 6, 2025
May 1, 2025
6.5 years
April 2, 2018
May 2, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Microbiome composition
Diversity analysis of microbiome samples in control subjects versus vitiligo subjects (measured by number of bacteria species/sample)
12 months
Disease Progression
Disease progression in control subjects versus vitiligo subjects (measured by VASI score (0-100)).
12 months
Secondary Outcomes (1)
Diet History Food Frequencies
12 months
Study Arms (2)
Adults with vitiligo
Healthy adults
Eligibility Criteria
Adults with or without vitiligo who are under the age of 90 years old.
You may qualify if:
- Patients with and/or without vitiligo lesional expansion over the past year.
- Age/sex-matched controls who do not have a diagnosis of vitiligo
- Subjects who are age 18-89 years of age at time of enrollment
- Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)
You may not qualify if:
- Subjects who are younger than 18 years of age or 90 years of age or older
- Subjects who are unable to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
I. Caroline Le Poole
Northwestern University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 2, 2018
First Posted
July 5, 2018
Study Start
May 30, 2019
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
May 6, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share